These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

205 related articles for article (PubMed ID: 25936561)

  • 21. 15d-Prostaglandin J2 induced reactive oxygen species-mediated apoptosis during experimental visceral leishmaniasis.
    Vishwakarma P; Parmar N; Yadav PK; Chandrakar P; Kar S
    J Mol Med (Berl); 2016 Jun; 94(6):695-710. PubMed ID: 26830627
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Targeted chemotherapy of visceral leishmaniasis by lactoferrin-appended amphotericin B-loaded nanoreservoir: in vitro and in vivo studies.
    Asthana S; Gupta PK; Jaiswal AK; Dube A; Chourasia MK
    Nanomedicine (Lond); 2015; 10(7):1093-109. PubMed ID: 25929567
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Antileishmanial activity of fullerol and its liposomal formulation in experimental models of visceral leishmaniasis.
    Ramos GS; Vallejos VMR; Ladeira MS; Reis PG; Souza DM; Machado YA; Ladeira LO; Pinheiro MBV; Melo MN; Fujiwara RT; Frézard F
    Biomed Pharmacother; 2021 Feb; 134():111120. PubMed ID: 33341671
    [TBL] [Abstract][Full Text] [Related]  

  • 24. In vitro and in vivo immunomodulatory properties of octyl-β-D-galactofuranoside during Leishmania donovani infection.
    Guegan H; Ory K; Belaz S; Jan A; Dion S; Legentil L; Manuel C; Lemiègre L; Vives T; Ferrières V; Gangneux JP; Robert-Gangneux F
    Parasit Vectors; 2019 Dec; 12(1):600. PubMed ID: 31870416
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Evaluation of the immunoprophylactic potential of a killed vaccine candidate in combination with different adjuvants against murine visceral leishmaniasis.
    Thakur A; Kaur H; Kaur S
    Parasitol Int; 2015 Feb; 64(1):70-8. PubMed ID: 25316605
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Lupeol and amphotericin B mediate synergistic anti-leishmanial immunomodulatory effects in Leishmania donovani-infected BALB/c mice.
    Das A; Jawed JJ; Das MC; Parveen S; Ghosh C; Majumdar S; Saha B; Bhattacharjee S
    Cytokine; 2021 Jan; 137():155319. PubMed ID: 33002744
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Oral administration of eugenol oleate cures experimental visceral leishmaniasis through cytokines abundance.
    Charan Raja MR; Kar A; Srinivasan S; Chellappan D; Debnath J; Kar Mahapatra S
    Cytokine; 2021 Sep; 145():155301. PubMed ID: 33127258
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Antileishmanial effect of cisplatin against murine visceral leishmaniasis.
    Kaur S; Sachdeva H; Dhuria S; Sharma M; Kaur T
    Parasitol Int; 2010 Mar; 59(1):62-9. PubMed ID: 19853668
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Withania somnifera chemotype NMITLI 101R significantly increases the efficacy of antileishmanial drugs by generating strong IFN-γ and IL-12 mediated immune responses in Leishmania donovani infected hamsters.
    Tripathi CD; Kushawaha PK; Sangwan RS; Mandal C; Misra-Bhattacharya S; Dube A
    Phytomedicine; 2017 Jan; 24():87-95. PubMed ID: 28160866
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Neutralization of IL-12 demonstrates the existence of discrete organ-specific phases in the control of Leishmania donovani.
    Engwerda CR; Murphy ML; Cotterell SE; Smelt SC; Kaye PM
    Eur J Immunol; 1998 Feb; 28(2):669-80. PubMed ID: 9521077
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Treatment of murine visceral leishmaniasis using an 8-hydroxyquinoline-containing polymeric micelle system.
    Duarte MC; Lage LM; Lage DP; Martins VT; Carvalho AM; Roatt BM; Menezes-Souza D; Tavares CA; Alves RJ; Barichello JM; Coelho EA
    Parasitol Int; 2016 Dec; 65(6 Pt A):728-736. PubMed ID: 27425599
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Targeting of immunostimulatory DNA cures experimental visceral leishmaniasis through nitric oxide up-regulation and T cell activation.
    Datta N; Mukherjee S; Das L; Das PK
    Eur J Immunol; 2003 Jun; 33(6):1508-18. PubMed ID: 12778468
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Protection against experimental visceral leishmaniasis by immunostimulation with herbal drugs derived from Withania somnifera and Asparagus racemosus.
    Kaur S; Chauhan K; Sachdeva H
    J Med Microbiol; 2014 Oct; 63(Pt 10):1328-1338. PubMed ID: 25082945
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Vaccination with poly(D,L-lactide-co-glycolide) nanoparticles loaded with soluble
    Margaroni M; Agallou M; Athanasiou E; Kammona O; Kiparissides C; Gaitanaki C; Karagouni E
    Int J Nanomedicine; 2017; 12():6169-6184. PubMed ID: 28883727
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Nanonization increases the antileishmanial efficacy of amphotericin B: an ex vivo approach.
    Manandhar KD; Yadav TP; Prajapati VK; Basukala O; Aganja RP; Dude A; Shrivastav ON; Sundar S
    Adv Exp Med Biol; 2014; 808():77-91. PubMed ID: 24595612
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Cationic solid-lipid nanoparticles are as efficient as electroporation in DNA vaccination against visceral leishmaniasis in mice.
    Saljoughian N; Zahedifard F; Doroud D; Doustdari F; Vasei M; Papadopoulou B; Rafati S
    Parasite Immunol; 2013 Dec; 35(12):397-408. PubMed ID: 23710803
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Therapeutic and immunomodulatory activities of short-course treatment of murine visceral leishmaniasis with KALSOME™10, a new liposomal amphotericin B.
    Asad M; Bhattacharya P; Banerjee A; Ali N
    BMC Infect Dis; 2015 Apr; 15():188. PubMed ID: 25884796
    [TBL] [Abstract][Full Text] [Related]  

  • 38. In vitro and in vivo antileishmanial efficacy of nitazoxanide against Leishmania donovani.
    Zhang R; Shang L; Jin H; Ma C; Wu Y; Liu Q; Xia Z; Wei F; Zhu XQ; Gao H
    Parasitol Res; 2010 Jul; 107(2):475-9. PubMed ID: 20495931
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The leishmanicidal activity of oleuropein is selectively regulated through inflammation- and oxidative stress-related genes.
    Kyriazis ID; Koutsoni OS; Aligiannis N; Karampetsou K; Skaltsounis AL; Dotsika E
    Parasit Vectors; 2016 Aug; 9(1):441. PubMed ID: 27501956
    [TBL] [Abstract][Full Text] [Related]  

  • 40. IL-33/ST2 axis is involved in disease progression in the spleen during Leishmania donovani infection.
    Lamberet A; Rostan O; Dion S; Jan A; Guegan H; Manuel C; Samson M; Gangneux JP; Robert-Gangneux F
    Parasit Vectors; 2020 Jun; 13(1):320. PubMed ID: 32571430
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.